Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Sanofi Teams Up with Regeneron on Cancer Immunotherapy Treatments

July 28, 2015 | by Stephanie Guzowski, Editor | News | Comments

French drugmaker Sanofi will pay at least $1.7 billon to enter a new collaboration with long-time partner Regeneron Pharmaceuticals in the development of cancer immunotherapies. Read more...

View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Roche's Atezolizumab Could Spur Long-Awaited Bladder Cancer Treatment Innovation

July 28, 2015 3:55 pm | by Cai Xuan, Ph.D., Oncology and Hematology, GlobalData | Articles | Comments

This observation opens up a market for companion biomarker tests that can be used to identify patients who would likely benefit from PD-1/PD-L1-targeted therapies. Read more...


Experimental MERS Vaccine Shows Promise in Animal Studies

July 28, 2015 3:47 pm | by NIAID | News | Comments

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques. Read more...


Merck Tops Street 2Q Forecasts Despite Lower Sales, Profits

July 28, 2015 3:42 pm | by Linda A. Johnson, AP Business Writer | News | Comments

The company noted experimental hepatitis C combination pill grazoprevir/elbasvir is now being reviewed by regulators in the U.S. and European Union. Read more...


Quality Standards for Pharma

July 28, 2015 3:26 pm | by Lindsay Hock, Editor | Articles | Comments

 Little do we think of the testing behind the medications prescribed to us that improve the quality of our lives. Yet, stringent testing is needed for any pharmaceutical or health care product to hit the shelves of your local convenience store. Read more...


ANI Pharmaceuticals, Sofgen Announce FDA Approval of Nimodipine 30mg Capsules

July 28, 2015 1:00 pm | News | Comments

ANI Pharmaceuticals, Inc. ("ANI") today announced that its ANDA collaboration partner Sofgen has received approval from the U.S. Food and Drug Administration (FDA) of the Abbreviated New Drug Application (ANDA) for Nimodipine 30mg Capsules.  Read more...


FDA Grants Breakthrough Therapy Designation to Eisai's Lenvatinib

July 28, 2015 12:58 pm | News | Comments

Eisai Inc. announced today the U.S. Food and Drug Administration (FDA) granted lenvatinib, the company's multiple receptor tyrosine kinase inhibitor, Breakthrough Therapy designation for the investigational use in patients with advanced or metastatic renal cell carcinoma (RCC) who were previously treated with a vascular endothelial growth factor (VEGF)-targeted therapy. Read more...


Study: Firms 'Underinvest' in Long-Term Cancer Research

July 28, 2015 8:53 am | by MIT | News | Comments

Pharmaceutical firms under invest in long-term research to develop new cancer-fighting drugs due to the greater time and cost required to conduct such research. Read more...


Innovative New Consortium Formed to Develop, Study Early Stage Drugs

July 28, 2015 8:46 am | by University of Cambridge | News | Comments

An innovative new Consortium will act as a match-making service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases. Read more...


New Material Opens up Possibilities for Super-Long-Acting Pills

July 28, 2015 8:40 am | by MIT | News | Comments

Medical devices designed to reside in the stomach have a variety of applications, including prolonged drug delivery, electronic monitoring, and weight-loss intervention. Read more...


Software Turns Smartphones into Tools for Medical Research

July 28, 2015 8:40 am | by Brandon Bailey, AP Technology Writer | News | Comments

Smartphone apps are the latest tools to emerge from the intersection of health care and Silicon Valley. Read more...


Early Antiretroviral Therapy Prevents non-AIDS Outcomes in HIV Infected People

July 28, 2015 8:40 am | by National Institute of Health | News | Comments

NIH-supported findings illustrate manifold benefit of therapy.


Sweet Revenge Against Superbugs

July 28, 2015 8:39 am | by University of Queensland | News | Comments

A special type of synthetic sugar could be the latest weapon in the fight against superbugs. Read more...


Central Nervous System (CNS) Summit 2015

July 27, 2015 3:37 pm | Events

CNS Summit, a community dedicated to shaping the future of drug development.

Predicting Whether Children With a Genetic Disorder Will Develop Autism, Psychosis: Study

July 27, 2015 11:21 am | by University of California, Los Angeles | News | Comments

Doctors and researchers have long known that children who are missing about 60 genes on a certain chromosome are at a significantly elevated risk for developing either a disorder on the autism spectrum or psychosis—that is, any mental disorder characterized by delusions and hallucinations, including schizophrenia. Read more...


AACC 2015: Research Expanded Upon for New Rapid Response Ebola Test

July 27, 2015 10:40 am | by Ryan Bushey, Associate Editor | Articles | Comments

The test is able to diagnose the virus in 15 minutes. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.